Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 3
1997 1
1998 1
1999 3
2000 1
2001 2
2002 2
2003 4
2004 1
2005 1
2006 5
2007 4
2008 3
2009 3
2010 8
2011 13
2012 15
2013 14
2014 6
2015 5
2016 4
2017 3
2018 2
2020 2
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group. Kappos L, et al. N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089952 Free article. Clinical Trial.
Treatment of MOG antibody associated disorders: results of an international survey.
Whittam DH, Karthikeayan V, Gibbons E, Kneen R, Chandratre S, Ciccarelli O, Hacohen Y, de Seze J, Deiva K, Hintzen RQ, Wildemann B, Jarius S, Kleiter I, Rostasy K, Huppke P, Hemmer B, Paul F, Aktas O, Pröbstel AK, Arrambide G, Tintore M, Amato MP, Nosadini M, Mancardi MM, Capobianco M, Illes Z, Siva A, Altintas A, Akman-Demir G, Pandit L, Apiwattankul M, Hor JY, Viswanathan S, Qiu W, Kim HJ, Nakashima I, Fujihara K, Ramanathan S, Dale RC, Boggild M, Broadley S, Lana-Peixoto MA, Sato DK, Tenembaum S, Cabre P, Wingerchuk DM, Weinshenker BG, Greenberg B, Matiello M, Klawiter EC, Bennett JL, Wallach AI, Kister I, Banwell BL, Traboulsee A, Pohl D, Palace J, Leite MI, Levy M, Marignier R, Solomon T, Lim M, Huda S, Jacob A. Whittam DH, et al. Among authors: akman demir g. J Neurol. 2020 Dec;267(12):3565-3577. doi: 10.1007/s00415-020-10026-y. Epub 2020 Jul 4. J Neurol. 2020. PMID: 32623595 Free PMC article.
Neuro-Behçet syndrome.
Saip S, Akman-Demir G, Siva A. Saip S, et al. Among authors: akman demir g. Handb Clin Neurol. 2014;121:1703-23. doi: 10.1016/B978-0-7020-4088-7.00110-3. Handb Clin Neurol. 2014. PMID: 24365442 Review.
Behçet's Disease and Nervous System Involvement.
Kürtüncü M, Tüzün E, Akman-Demir G. Kürtüncü M, et al. Among authors: akman demir g. Curr Treat Options Neurol. 2016 May;18(5):19. doi: 10.1007/s11940-016-0405-6. Curr Treat Options Neurol. 2016. PMID: 27007988 Review.
Behçet's Disease.
Akman-Demir G, Saip S, Siva A. Akman-Demir G, et al. Curr Treat Options Neurol. 2011 Jun;13(3):290-310. doi: 10.1007/s11940-011-0120-2. Curr Treat Options Neurol. 2011. PMID: 21416331
Neuro-Behçet's Disease with Chorea.
Gür Özmen S, Hanağasi H, Gürvit H, Emre M, Akman Demir G. Gür Özmen S, et al. Among authors: akman demir g. Noro Psikiyatr Ars. 2015 Jun;52(2):200-201. doi: 10.5152/npa.2015.7316. Epub 2015 Jun 1. Noro Psikiyatr Ars. 2015. PMID: 28360705 Free PMC article.
Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment.
Sen S, Tuncer A, Terzi M, Bunul SD, Ozen-Acar P, Altunrende B, Ozakbas S, Tutuncu M, Uygunoglu U, Akman-Demir G, Karabudak R, Efendi H, Siva A. Sen S, et al. Among authors: akman demir g. Mult Scler Relat Disord. 2023 Nov;79:104949. doi: 10.1016/j.msard.2023.104949. Epub 2023 Aug 25. Mult Scler Relat Disord. 2023. PMID: 37678131
95 results